StockData
Incyte Corp logo

Incyte Corp (INCY) stock

INCYNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 13/3091% above fair value
$117.80−1.29 (-1.08%)

Close on Nov 18, 2026Market cap $24.01BP/E 62.7Yield –

Incyte operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Incyte's operating income for the twelve months ending Sep 30, 2026 was $626.51M, down 57.7% year over year. For fiscal 2025 it was $1.51B, up 2368.6% from the year before. Over ten years it grew 40.5% a year on average. The highest annual figure on record is $1.51B in fiscal 2025.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.51B+2368.6%
FY2024Dec 31, 2024$61.37M-90.1%
FY2023Dec 31, 2023$620.53M+7.1%
FY2022Dec 31, 2022$579.44M-1.1%
FY2021Dec 31, 2021$585.78M–
FY2020Dec 31, 2020-$263.68M-165.6%
FY2019Dec 31, 2019$402.01M+211.1%
FY2018Dec 31, 2018$129.22M–
FY2017Dec 31, 2017-$243.39M-267.9%
FY2016Dec 31, 2016$145.00M+186.3%
FY2015Dec 31, 2015$50.65M–
FY2014Dec 31, 2014-$4.80M–
FY2013Dec 31, 2013-$16.10M-1502.6%
FY2012Dec 31, 2012$1.15M–
FY2011Dec 31, 2011-$143.18M-1119.2%
FY2010Dec 31, 2010$14.05M–
FY2009Dec 31, 2009-$139.77M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$708.36M-259.7%
Q2 FY2026Jun 30, 2026$697.90M+31.6%
Q1 FY2026Mar 31, 2026$301.12M+46.8%
Q4 FY2025Dec 31, 2025$335.86M+11.4%
Q3 FY2025Sep 30, 2025$443.52M+203.6%
Q2 FY2025Jun 30, 2025$530.31M–
Q1 FY2025Mar 31, 2025$205.17M+123.3%
Q4 FY2024Dec 31, 2024$301.51M+61.0%
Q3 FY2024Sep 30, 2024$146.09M-32.0%
Q2 FY2024Jun 30, 2024-$478.13M-346.7%
Q1 FY2024Mar 31, 2024$91.90M+271.0%
Q4 FY2023Dec 31, 2023$187.27M+167.2%
Q3 FY2023Sep 30, 2023$214.71M+55.2%
Q2 FY2023Jun 30, 2023$193.78M-23.8%
Q1 FY2023Mar 31, 2023$24.77M-78.7%
Q4 FY2022Dec 31, 2022$70.09M-36.7%
Q3 FY2022Sep 30, 2022$138.38M-41.2%
Q2 FY2022Jun 30, 2022$254.43M+80.7%
Q1 FY2022Mar 31, 2022$116.54M+18.0%
Q4 FY2021Dec 31, 2021$110.73M-32.6%
Q3 FY2021Sep 30, 2021$235.41M+4320.0%
Q2 FY2021Jun 30, 2021$140.84M-39.0%
Q1 FY2021Mar 31, 2021$98.80M–
Q4 FY2020Dec 31, 2020$164.23M+72.9%
Q3 FY2020Sep 30, 2020$5.33M-96.0%
Q2 FY2020Jun 30, 2020$230.77M+134.0%
Q1 FY2020Mar 31, 2020-$664.00M-996.5%
Q4 FY2019Dec 31, 2019$95.01M+15.9%
Q3 FY2019Sep 30, 2019$134.32M+331.6%
Q2 FY2019Jun 30, 2019$98.61M+18.5%
Q1 FY2019Mar 31, 2019$74.07M–
Q4 FY2018Dec 31, 2018$81.98M–
Q3 FY2018Sep 30, 2018$31.12M+107.2%
Q2 FY2018Jun 30, 2018$83.24M+1046.7%
Q1 FY2018Mar 31, 2018-$67.11M–
Q4 FY2017Dec 31, 2017-$132.42M-414.7%
Q3 FY2017Sep 30, 2017$15.02M–
Q2 FY2017Jun 30, 2017$7.26M–
Q1 FY2017Mar 31, 2017-$133.25M–
Q4 FY2016Dec 31, 2016$42.08M–

More Incyte figures

See a number that looks wrong?